Boris I. Chobrutskiy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity”.

Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity

Molecular Immunology(2022)10.1016/j.molimm.2022.08.001

N/A

0DataRank · unranked

28 citations

Andrea Chobrutskiy, Jamie K. Teer, Dhruv N. Patel, Monica Hsiang, Taha I. Huda +7 more

Clinical predictors for thrombus progression in cirrhotic patients with untreated splanchnic vein thrombosis

Thrombosis Research(2022)10.1016/j.thromres.2022.05.012

N/A

0DataRank · unranked

9 citations

Jean M.G. Sabile, Benjamin Elstrott, Boris I. Chobrutskiy, Ajay Mohinani, Sarah Patel +4 more

Immune receptor CDR3 chemical features that preserve sequence information are highly efficient in reflecting survival distinctions: A pan‑cancer analysis

Biomedical Reports(2022)10.3892/br.2022.1551

N/A

0DataRank · unranked

0 citations

Boris I. Chobrutskiy, Andrea Chobrutskiy, Etienne C. Gozlan, Michael J. Diaz, George Blanck +1 more

Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression

Cancer Informatics(2023)10.1177/11769351231177269

N/A

0DataRank · unranked

15 citations

Andrea Chobrutskiy, Dhruv N. Patel, Monica Hsiang, Saif Zaman, Konrad J. Cios +3 more

Predictors of thrombosis during VV ECMO: an analysis of 9809 patients from the ELSO registry

Journal of Thrombosis and Thrombolysis(2023)10.1007/s11239-023-02909-4

N/A

0DataRank · unranked

7 citations

Benjamin R. Weeder, Boris I. Chobrutskiy, Thomas Kartika, Kerry Moore, Owen J. T. McCarty +4 more

A Bioinformatics Assessment Indicating Better Outcomes With Breast Cancer Resident, Immunoglobulin CDR3-MMP2 Binding

Cancer Genomics & Proteomics(2023)10.21873/cgp.20378

N/A

0DataRank · unranked

0 citations

ALEXIS J. THOMSON, Etienne C. Gozlan, Dhruv N. Patel, Andrea Chobrutskiy, Boris I. Chobrutskiy +2 more

Perinatal Outcomes Following Intravenous Iron for Treatment of Iron Deficiency With and Without Anemia

European Journal Of Haematology(2024)10.1111/ejh.14298

N/A

0DataRank · unranked

4 citations

Kylee L. Martens, Bharti Garg, Boris I. Chobrutskiy, Madeline A. Hedges, Olivia L. Hagen +8 more

Adaptive Immune Receptor Distinctions Along the Colorectal Polyp-Tumor Timelapse

Clinical Colorectal Cancer(2024)10.1016/j.clcc.2024.07.002

N/A

0DataRank · unranked

1 citations

Diep Nguyen, Arpan Sahoo, Joanna J. Song, Alexander F. Gutierrez, Boris I. Chobrutskiy +2 more

Survival Distinctions for Cases Representing Immunologically Cold Tumors via Intrinsic Disorder Assessments for Blood-Sourced TRB Variable Regions

International Journal of Molecular Sciences(2024)10.3390/ijms252111691

N/A

0DataRank · unranked

1 citations

Etienne C. Gozlan, Joanna J. Song, George Angelakakis, Michelle Yeagley, Boris I. Chobrutskiy +3 more

Chemical complementarity of tumor resident, T-cell receptor CDR3s and renalase-1 correlates with increased melanoma survival

Oncotarget(2024)10.18632/oncotarget.28633

N/A

0DataRank · unranked

0 citations

Fred S. Gorelick, Andrea Chrobrutskiy, Boris I. Chobrutskiy, Gary V. Désir, George Blanck +1 more